British-Swedish pharmaceutical company
AstraZeneca ▸ Facts ▸ Comments ▸ News ▸ Videos
Covid vaccinations start at Boots branch in Halifax
Credit: ODN Duration: 01:25Published
COVID vaccine: From factory to arm, the logistics of rolling out the Oxford-AstraZeneca jab
Credit: Euronews English Duration: 02:33Published
Joan Collins gets COVID-19 vaccine and urges others to do the same
Credit: Cover Video STUDIO Duration: 00:42Published
Explained: India announces Covid vaccination launch date; who's first in line?
Credit: HT Digital Content Duration: 01:34Published
UK approves Moderna Covid-19 vaccine
Credit: PA - Press Association STUDIO Duration: 00:59Published
COVID-19 Vaccines Are Making Their Way Around The World
Credit: Wochit News Duration: 00:39Published
100-year-old Ellen Prosser among first care home residents to receive Oxford vaccine
Credit: PA - Press Association STUDIO Duration: 00:40Published
GP nurse receives Oxford-AstraZeneca vaccine at surgery
Credit: PA - Press Association STUDIO Duration: 00:46Published
Matt Hancock calls on Donald Trump to condemn violent scenes at US Capitol
Credit: PA - Press Association STUDIO Duration: 00:58Published
Covid: What led to DCGI nod of Covishield & Covaxin in India? IMCR DG explains
Credit: HT Digital Content Duration: 04:32Published
'Who will opt for vaccine...': Congress questions approval, slams govt
Credit: HT Digital Content Duration: 03:25Published
Rollout of Oxford Covid-19 vaccine begins in Scotland
Credit: PA - Press Association STUDIO Duration: 00:46Published
UK is first country in the world to rollout Oxford-AstraZeneca vaccine
Credit: euronews (in English) Duration: 00:50Published
I feel privileged to have given first vaccine, says nurse
Credit: ODN Duration: 00:40Published
'I'm from farmer family...': Vaccine-maker Bharat Biotech's MD on controversy
Credit: HT Digital Content Duration: 08:59Published
Pensioner receives Oxford jab in Belfast
Credit: PA - Press Association STUDIO Duration: 01:18Published
UK inoculates first patient with Oxford/AstraZeneca COVID-19 vaccine
Credit: Euronews English Duration: 01:37Published
COVAXIN has shown less than 10% adverse reactions: Bharat Biotech MD
Credit: ANI Duration: 01:42Published
Britain's Johnson visits hospital as Oxford vaccine rollout begins
Credit: Reuters Studio Duration: 01:06Published
'Gamechanger' to have Oxford-AstraZeneca says Powis
Credit: ODN Duration: 01:51Published
First Oxford vaccine dose administered in UK
Credit: ODN Duration: 01:26Published
Tougher action needed to curb coronavirus spread says PM
Credit: ODN Duration: 01:48Published
You Might Like
Serum Institute expects WHO emergency approval for AstraZeneca shot soonThe Serum Institute of India expects WHO emergency-use authorization soon for the Oxford University/AstraZeneca coronavirus vaccine, which it is producing for mid and low income countries, its chief..
AstraZeneca 'on track' to deliver two million doses a week - as it calls for priority accessAstraZeneca says it expects to release two million doses of the Oxford vaccine every week by mid-February - and has asked for its workers to get priority access to avoid COVID outbreaks hindering..
Covid vaccine recipients may not be able to pick & chooseEven as the government plans to roll out the Covid vaccination drive with Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin, recipients may not have an option to choose which one they..
SII gets order for 11 million vaccine doses, trucks ready for transportationThe process of transporting Covishield vaccine began on Monday after the Serum Institute of India (SII) received the Centre’s initial purchase order for 11 million doses at Rs 200 per dose. This..
India wants Serum Institute to lower price of AstraZeneca shot, say sourcesThe Indian government has been negotiating with the Serum Institute of India to bring down the price of AstraZeneca's Covid-19 vaccine, delaying the roll-out of the country's immunisation programme...
Brazil's Bolsonaro asks India to expedite Covid vaccine shipment as delays loomBrazilian President Jair Bolsonaro asked Prime Minister Narendra Modi to expedite a shipment of AstraZeneca's Covid-19 vaccine amid broader delays to the vaccine's arrival in Brazil, according to a..
Surgery visited by Hancock to mark Oxford/AstraZeneca jab rollout has delivery of it delayedThe GP surgery visited by the health secretary to mark the expanded rollout of the Oxford/AstraZeneca coronavirus vaccine has not yet received any of it.
COVID-19: GPs join biggest vaccination programme in NHS historyGP surgeries in England are to begin rolling out the Oxford/AstraZeneca coronavirus jab as part of the biggest vaccination programme in NHS history.
All-India vaccine rollout set for next week: GovtThe government will roll out the Covid-19 vaccine next week, with health secretary Rajesh Bhushan saying this was set to happen within 10 days of emergency use authorisation being granted. The Indian..
All Indian vaccines being developed for storage at 2-8 degree Celsius: DBT secretarySwarup said Dr Reddy's Laboratories has partnered with Russia's Gamaleya Institute and a vaccine is being developed for India targeting storage at 2-8 degrees Celsius. The country's drugs regulator..
82-year-old man first to receive Oxford-AstraZeneca vaccine in UKAn 82-year-old man has become the first person in the UK to receive the Oxford-AstraZeneca vaccine since it was approved for use.
'Pivotal moment': First doses of Oxford University-AstraZeneca vaccine to be given todayThe first doses of the Oxford University-AstraZeneca vaccine will be administered in the UK today in what the government has described as a "pivotal moment" in the fight against coronavirus.
Serum Institute says to meet local demand for AstraZeneca vaccine for next two months before exportingSerum Institute of India (SII), the local maker of the AstraZeneca/Oxford coronavirus vaccine, said on Sunday it intends to concentrate on meeting India's own immediate demand in the next two months..
Bharat Biotech’s Covaxin too gets nod for emergency useIndia's vaccine rollout will begin with the availability of two jabs- Oxford-Astra Zeneca's Covishield and Bharat Biotech's homegrown Covaxin- with the Drugs Controller General of India expected to..
Son of oldest NHS doctor to die with COVID calls for health workers to get vaccine firstThe son of the oldest NHS frontline doctor to die after contracting COVID-19 says health and care workers should be the first to receive the Oxford/AstraZeneca coronavirus vaccine.
Batches of Oxford/AstraZeneca vaccine arrive at UK hospitals ahead of nationwide roll-outBatches of the Oxford/AstraZeneca coronavirus vaccine have started arriving at UK hospitals ahead of the jab's nationwide roll-out.
COVID-19: India gives nod to AstraZeneca's Covishield vaccine for mass immunisationIt is the first COVID-19 vaccine to be approved for emergency use by India, which has the highest number of infections after the United States.
Happy New Year: Expert panel clears Oxford vaccine for IndiaIndia moved closer to the rollout of its vaccination plan against Covid-19 with the subject expert committee of the drug regulator on Friday recommending emergency-use authorisation (EUA) for Serum..
India set to approve its first Covid vaccine; nationwide dry run tomorrowA day ahead of the nationwide Covid-19 vaccination dry run, the Indian drug regulator's expert panel on Friday cleared the decks for emergency use authorisation for the vaccine developed by AstraZeneca..
Oxford Covid vaccine set to become first to get approval in India: ReportThe expert panel is likely to approve the vaccine developed by AstraZeneca and Oxford University for emergency use on Friday, Reuters reported quoting sources. If approved, India will become the third..
India's drug regulator to meet again on January 1 to discuss AstraZeneca vaccineCDSCO, India's drug regulator will meet on Friday to consider approving AstraZeneca and Oxford University's Covid-19 vaccine for emergency use. SII, the world's biggest vaccine producer, has already..
UK approval of Oxford-AstraZeneca Covid-19 vaccine positive news, waiting for India's approval: Serum Institute
Covaxin can offer protection against mutated coronavirus: Bharat BiotechVaccine makers like Pfizer and AstraZeneca have also said that their vaccines against Covid-19 should work against the new strain.
Covid-19: Oxford vaccine may get nod in a few daysIndia is likely to see the Oxford-AstraZeneca vaccine being approved for emergency use in next few days as the updated data submitted by Serum Institute of India (SII) appears “satisfactory”, top..
India likely to approve AstraZeneca vaccine by next weekThis could be the first country to give the regulatory green light for the British drugmaker’s vaccine as the British medicine regulator continues to examine data from the trials. The..
Our vaccine can be effective against new coronavirus variant: AstraZenecaDrugmakers are scrambling to test their COVID-19 vaccines against the new fast-spreading variant of the virus that is raging in Britain.
India requires Rs 80,000 crore for vaccine distribution next year: SIINEW DELHI: Pune-based vaccine-maker Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, on Saturday said that the country would require a..
Oxford-AstraZeneca's Covid vaccine can be available in India by 1st half of next year: Official
India readies for 60 crore COVID vaccine jabs; to use standard cold storageIndian regulators are considering 3 vaccines for emergency use authorisation, including those from Pfizer Inc, AstraZeneca and Bharat Biotech.
India speeding up review of Pfizer, Astra Covid-19 vaccines: Govt officialIndia is accelerating its review of coronavirus vaccines developed by Pfizer Inc and AstraZeneca for emergency use, a senior government official said on Monday, as the world's second-most affected..
Covid-19: India pins hopes on 4 vaccines to inoculate 30 crore by JulyThe government is expecting two vaccines against Covid-19 — Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin — to be available by January and around four vaccines by the end of..
AstraZeneca to sell 2.5 billion shots to 17 countriesData shows that seven vaccine makers together have confirmed contracts to supply 6.2 billion doses of vaccines to a pool of around 20 countries, while another 12 vaccine makers together have deals for..
AstraZeneca partner sticks with two full dose regimen in Covid trials in IndiaThe British drugmaker has said its Covid-19 vaccine could be up to 90% effective if administered as a half dose followed by a full dose, but some scientists have questioned the robustness of that..
Serum says AstraZeneca's Covid-19 vaccine safe, no co-relation with side-effectsSerum Institute of India, the world's largest vaccine manufacturer, on Tuesday denied allegations that a Covid-19 trial volunteer suffered serious side effects from a vaccine developed by AstraZeneca..
India looking to be self-reliant in development, production of vaccine against Covid-19While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass production of Covishield vaccine developed by Oxford -Astra..
Gujarat: PM Modi reviews vaccine development at Zydus Cadila facilityPrime Minister Narendra Modi on Saturday began his three-city visit to review coronavirus vaccine development work by going to pharma major Zydus Cadila's manufacturing facility near Ahmedabad. After..
Vaccine tour: PM Modi arrives at SII in Pune to review COVID-19 vaccine developmentThe Serum Institute of India has partnered with global pharma giant AstraZeneca and Oxford University for the vaccine.
PM to visit vaccine centres in 3 citiesWhile in Hyderabad, the PM will visit vaccine maker Bharat Biotech’s facilities, where work on the development of India’s first indigenous Covid-19 vaccine, Covaxin, is under way, he will drop in..
India to consider clinical trials data of two full doses of AstraZeneca vaccineIndia will consider clinical trial data for the two full-dose Oxford-AstraZeneca Covid-19 vaccine candidate which the firm says has an efficacy of 62% and not the “half plus full” dose regime which..
AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum InstituteVaccine major Serum Institute of India on Thursday said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly with..
AstraZeneca inks pact with Research Society for Study of Diabetes in India
Covid-19: PM Modi to visit Serum Institute of India in Pune on Nov 28Prime Minister Narendra Modi will on Saturday visit the Pune-based Serum Institute of India, which has partnered with global pharma giant AstraZeneca and the Oxford University for Covid-19 vaccine, a..
Also reported by •DNA
AstraZeneca manufacturing error clouds vaccine study resultsIn a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses. In the low-dose group, AstraZeneca said, the vaccine appeared..
Oxford vaccine ‘70% effective’, may get India nod by year-endArmed with interim findings of the AstraZeneca-Oxford Covid-19 vaccine trials — which showed 70% effectiveness in preventing people from getting infected — Pune-based Serum Institute of India (SII)..
After Pfizer and Moderna, Oxford-AstraZeneca claims 90% efficacy of COVID-19 vaccineAccording to the Oxford University release, no volunteer complained of any medical issue during the trial of the vaccine.
Covid-19: Govt may get Oxford shots in Jan-Feb, at 50% of MRPIndia is likely to get the first lot of anti-Covid shots in late January-early February. This will be possible as India plans to give Serum Institute of India emergency use approval for the..
As race for vax nears last lap, Modi reviews India’s strategyPrime Minister Narendra Modi on Friday held a review of India’s vaccination strategy amid indications that the fast-developing Oxford-AstraZeneca shot may be eligible for emergency use authorisation..
India could get access to AstraZeneca vaccine by January, says local manufacturer
Indians to get 'Covishield' vaccine for Rs 500-600, govt to get it at even lesser price'Covishield', the frontrunner to India's race for Covid-19 vaccine, is manufactured by Serum Institute of India in agreement with Oxford-AstraZeneca.
India to get 100 million doses of Oxford COVID-19 vaccine by Dec, says Adar PoonawallaSII, which has tied up with five developers, has so far made 40 million doses of AstraZeneca vaccine in the past two months and aims to start manufacturing Novavax's contender soon.